Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

730 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma.
Sato Y, Nabeta Y, Tsukahara T, Hirohashi Y, Syunsui R, Maeda A, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Wada T, Yamashita T, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Umeda T, Ishii S, Kawaguchi S, Sato N. Sato Y, et al. Among authors: araki n. J Immunol. 2002 Aug 1;169(3):1611-8. doi: 10.4049/jimmunol.169.3.1611. J Immunol. 2002. PMID: 12133991
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute.
Ida K, Kawaguchi S, Sato Y, Tsukahara T, Nabeta Y, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Kamiguchi K, Wada T, Nagoya S, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Ozaki T, Yoshikawa H, Yamashita T, Sato N. Ida K, et al. Among authors: araki n. J Immunol. 2004 Jul 15;173(2):1436-43. doi: 10.4049/jimmunol.173.2.1436. J Immunol. 2004. PMID: 15240740
Extraskeletal myxoid chondrosarcoma: a Multi-Institutional Study of 42 Cases in Japan.
Kawaguchi S, Wada T, Nagoya S, Ikeda T, Isu K, Yamashiro K, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Umeda T, Yoshikawa H, Hasegawa T; Multi-Institutional Study of 42 Cases in Japan. Kawaguchi S, et al. Among authors: araki n. Cancer. 2003 Mar 1;97(5):1285-92. doi: 10.1002/cncr.11162. Cancer. 2003. PMID: 12599237 Free article.
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.
Kawai A, Araki N, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Tanase T, Hasegawa T, Takahashi S. Kawai A, et al. Among authors: araki n. Lancet Oncol. 2015 Apr;16(4):406-16. doi: 10.1016/S1470-2045(15)70098-7. Epub 2015 Mar 18. Lancet Oncol. 2015. PMID: 25795406 Clinical Trial.
The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Nakamura T, Matsumine A, Kawai A, Araki N, Goto T, Yonemoto T, Sugiura H, Nishida Y, Hiraga H, Honoki K, Yasuda T, Boku S, Sudo A, Ueda T. Nakamura T, et al. Among authors: araki n. Cancer. 2016 May 1;122(9):1408-16. doi: 10.1002/cncr.29961. Epub 2016 Mar 11. Cancer. 2016. PMID: 26970174 Free PMC article.
Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy.
Araki N, Takahashi S, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Kawai A. Araki N, et al. Eur J Cancer. 2016 Mar;56:122-130. doi: 10.1016/j.ejca.2015.12.014. Epub 2016 Feb 2. Eur J Cancer. 2016. PMID: 26845175 Free article.
730 results